1.
Mahadkar N, Dhoot DS, Barkate H. Comparative real-world effectiveness and safety of super-bioavailable itraconazole 50 mg bd and 65 mg bd in the management of dermatophytosis. Int J Res Dermatol [Internet]. 2022 Jun. 24 [cited 2026 Apr. 16];8(4):433-6. Available from: https://www.ijord.com/index.php/ijord/article/view/1562